Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Shergill
A. Shergill
Imprime PGG
Pembrolizumab
Medicine
Oncology
Internal medicine
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P77.05 Phase II Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC After Progression on First-Line Therapy: BTCRC-LUN15-017
2021
Journal of Thoracic Oncology
E. Sisel
Muhammad Furqan
Jyoti Malhotra
A. Shergill
K. Kennedy
L. Liu
Mary Pasquinelli
Lawrence E. Feldman
Show All
Source
Cite
Save
Citations (0)
FP04.04 A Phase Ib/II Study of Imprime PGG and Pembrolizumab in Pretreated Patients With Advanced Stage Non-Small Cell Lung Cancer: BTCRC-LUN15-017
2021
Journal of Thoracic Oncology
Muhammad Furqan
Jyoti Malhotra
Li Liu
H. Wang
Mary Pasquinelli
E. Sisel
K. Kennedy
A. Shergill
Lawrence Eric Feldman
Show All
Source
Cite
Save
Citations (0)
P1.01-86 BTCRC-LUN15-017: Phase-Ib Study of Imprime PGG and Pembrolizumab in Stage IV NSCLC after Progression on Platinum Based Therapy
2018
Journal of Thoracic Oncology
A. Shergill
M. Furqan
J. Malhotra
L. Liu
N Bose
C. Belani
L. Feldman
Show All
Source
Cite
Save
Citations (1)
1